(PharmaNewsWire.Com, April 19, 2017 ) Neonatal Neurosonography is also called as Neonatal Neuroultrasound, uses high frequency sound waves to generate an images for the assessment and diagnosis of neurological system in the neonates.
There are number of neurological conditions that leads to the morbidity and mortality of the neonates, most of them can be identified with Neonatal Neurosonography. The factors contributing for the usage of Neonatal Neurosonography is the safety, reliability, early and serial imaging, inexpensive, reproducible and highly suitable for screening. Neonatal neurosonography is more advantageous than others, as it does not require use of radiations, sedation, and is portable. Looping technology in Neonatal Neurosonography allows to take individual images which can be easily compiled. Most of the Neonatal Neurosonography is performed bedside with the neonate within the incubator. Care should be taken to prevent the movement and disturbances during the usage of Neonatal Neurosonography. Aseptic conditions should be maintained during the usage of Neonatal Neurosonography. Generally six to eight images are formed during the process of Neonatal Neurosonography.
Large number of cerebral damages occur in the early stages and early intervention in such cases is more successful. Because of high incidence on disorders and diseases, Neonatal Neurosonography is required in most of the neonates. Neonatal Neurosonography is more versatile than others and with detailed anatomic imaging. Recent advances in Neonatal Neurosonography optimizes the real time images and help in the quick and accurate identification of disease condition. The usage of neonatal neurosonography reduces the risk of accident associated with the physiology of the neonates and incidence of unintended complications. There is no contraindication associated with usage of Neonatal Neurosonography. All these factors act as a driving principle towards the development of the Neonatal Neurosonography market.
Information regarding pathology is obtained only with high frequencies phased array transducer of Neonatal Neurosonography. In some cases, extra procedures are required to understand the pathology. Detection of every condition is not possible with Neonatal Neurosonography. In some cases, CT scan is more useful over Neonatal Neurosonography because of more accurate information. All these act as restraints in the advancement of Neonatal Neurosonography market.
With rapid advancement of technology, the Neonatal Neurosonography become more compact, portable and less expensive with high quality images. Because of the availability of the portable Neonatal Neurosonography instruments in the market, made it possible to use in critical care and emergency situations. A technological improvement in Neonatal Neurosonography increases the efficiency of research investigation by reducing the number required in the research. The growth in Neonatal Neurosonography market is expected more because reduced cost burden on the patients by the insurance companies. Other factors contributing for the growth is increased number of the natality cases around the globe. The increased risk of pathological conditions in neonatal with increased new born population drives towards rapid advancement of the neonatal neurosonography market. Whereas in some cases, the complexity of neurological system limiting the efficacy and application of neonatal neurosonography which hampers the growth of the neonatal neurosonography market. Because of side effects and risk associated with application of the neonatal neurosonography is less significant, the usage of neonatal neurosonography is high when compared to the others techniques. Whereas other techniques require high maintenance cost which make the neonatal neurosonography use more. All this makes the neonatal neurosonography market more strong and the future is expected to grow with double growth rate.
The growth of neonatal neurosonography market is high for United States. Other parts of the world like Europe, Asia-pacific and Middle East countries also observed a significant growth in neonatal neurosonography market from the past few years. Whereas the growth in neonatal neurosonography market in the underdeveloped countries is comparatively at slow pace.
Key participants in the neonatal neurosonography market are GE Healthcare, Siemens Healthcare, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Esaote and others playing important role around the globe.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
